CETN1

gene
On this page

Also known as CEN1

Summary

CETN1 (centrin 1, HGNC:1866) is a protein-coding gene on chromosome 18p11.32, encoding Centrin-1 (Q12798). Plays a fundamental role in microtubule-organizing center structure and function.

The protein encoded by this gene plays important roles in the determination of centrosome position and segregation, and in the process of microtubule severing. This protein is localized to the centrosome of interphase cells, and redistributes to the region of the spindle poles during mitosis, reflecting the dynamic behavior of the centrosome during the cell cycle.

Source: NCBI Gene 1068 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 33 total — 1 pathogenic
  • MANE Select transcript: NM_004066

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:1866
Approved symbolCETN1
Namecentrin 1
Location18p11.32
Locus typegene with protein product
StatusApproved
AliasesCEN1
Ensembl geneENSG00000177143
Ensembl biotypeprotein_coding
OMIM603187
Entrez1068

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000327228

RefSeq mRNA: 1 — MANE Select: NM_004066 NM_004066

CCDS: CCDS11820

Canonical transcript exons

ENST00000327228 — 1 exons

ExonStartEnd
ENSE00001231082580380582114

Expression profiles

Bgee: expression breadth broad, 32 present calls, max score 97.30.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2966 / max 316.6617, expressed in 5 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1690520.25114
1690510.04553

Top tissues by expression

247 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453397.30gold quality
right testisUBERON:000453497.14gold quality
testisUBERON:000047393.72gold quality
spermCL:000001992.23gold quality
male germ cellCL:000001591.42gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.90gold quality
adult organismUBERON:000702381.70gold quality
olfactory bulbUBERON:000226478.54gold quality
type B pancreatic cellCL:000016978.46gold quality
diaphragmUBERON:000110375.04gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451172.60gold quality
hair follicleUBERON:000207372.34gold quality
oocyteCL:000002369.52gold quality
pancreatic ductal cellCL:000207968.56silver quality
epithelial cell of pancreasCL:000008367.60gold quality
mucosa of paranasal sinusUBERON:000503065.20gold quality
upper arm skinUBERON:000426364.78gold quality
mucosa of urinary bladderUBERON:000125964.36gold quality
epithelium of nasopharynxUBERON:000195163.85gold quality
gingival epitheliumUBERON:000194963.84gold quality
mammary ductUBERON:000176563.49gold quality
cervix epitheliumUBERON:000480163.38gold quality
secondary oocyteCL:000065563.23gold quality
ileal mucosaUBERON:000033163.18silver quality
epithelium of mammary glandUBERON:000324463.02gold quality
thymusUBERON:000237062.18gold quality
cervix squamous epitheliumUBERON:000692261.70gold quality
gingivaUBERON:000182861.37gold quality
cardia of stomachUBERON:000116260.98gold quality
tongue squamous epitheliumUBERON:000691960.97gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-134144yes29.55
E-ANND-3no1.31

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

47 targeting CETN1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-548P99.9872.253784
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-806399.9169.763146
HSA-MIR-374A-5P99.9071.342923
HSA-MIR-205-5P99.8170.051557
HSA-MIR-6842-5P99.8067.541587
HSA-MIR-7110-5P99.8067.841712
HSA-MIR-7856-5P99.7569.992901
HSA-MIR-3913-3P99.7466.53938
HSA-MIR-580-3P99.6769.231841
HSA-MIR-4690-5P99.6566.24813
HSA-MIR-26A-1-3P99.6466.81788
HSA-MIR-26A-2-3P99.6466.82786
HSA-MIR-6752-5P99.5967.321243
HSA-MIR-448999.5065.56785
HSA-MIR-464399.4967.631791
HSA-MIR-608199.4866.071446
HSA-MIR-21-5P99.4670.541035
HSA-MIR-888-5P99.3070.151855
HSA-MIR-590-5P99.2570.76930
HSA-MIR-4477B99.2370.491733
HSA-MIR-6510-5P99.1466.591081
HSA-MIR-548AS-3P99.1269.122294
HSA-MIR-6506-5P99.0465.661386
HSA-MIR-155-3P99.0367.99924
HSA-MIR-423-5P98.6967.481522
HSA-MIR-619-5P98.5764.971988
HSA-MIR-3184-5P98.5667.131491

Literature-anchored findings (GeneRIF, showing 7)

  • These data demonstrate a functional role for CaM binding to CP110 and suggest that CP110 cooperates with CaM and centrin to regulate progression through cytokinesis. (PMID:16760425)
  • CETN1 is overexpressed in breast cancer tissue and promotes cells’proliferation, tumor growth and metastasis. (PMID:25261648)
  • A chirality change in XPC- and Sfi1-derived peptides affects their affinity for centrin. (PMID:26923803)
  • important spectral and hydrodynamic characteristics of human Centrin-1, accounting that HsCentrin-1 has moderate affinity for Ca(2+). Centrin-1 does not gain structure as seen by far- and near-UV circular dichroism, rather there is a loss of ellipticity, though inconsiderable upon binding Ca(2+). (PMID:27235176)
  • Conformational scanning of individual EF-hand motifs of calcium sensor protein centrin-1. (PMID:34273620)
  • Exome sequencing and functional analyses revealed CETN1 variants leads to impaired cell division and male fertility. (PMID:36048845)
  • Human SFI1 and Centrin form a complex critical for centriole architecture and ciliogenesis. (PMID:36125182)

Cross-species orthologs

11 orthologs

OrganismSymbolGene ID
danio_reriocetn2ENSDARG00000101510
mus_musculusCetn1ENSMUSG00000050996
rattus_norvegicusCetn1ENSRNOG00000084288
drosophila_melanogasterCG17493FBGN0040010
drosophila_melanogasterCG31802FBGN0051802
caenorhabditis_elegansWBGENE00000285
caenorhabditis_elegansWBGENE00000287
caenorhabditis_eleganspat-10WBGENE00003934
caenorhabditis_elegansWBGENE00008453
caenorhabditis_elegansF35C12.3WBGENE00009408
caenorhabditis_elegansWBGENE00015264

Paralogs (20): CABP7 (ENSG00000100314), CABP5 (ENSG00000105507), CALML4 (ENSG00000129007), CALM2 (ENSG00000143933), CETN2 (ENSG00000147400), CETN3 (ENSG00000153140), CABP1 (ENSG00000157782), CALM3 (ENSG00000160014), CABP2 (ENSG00000167791), CALML6 (ENSG00000169885), EFCAB3 (ENSG00000172421), EFCAB12 (ENSG00000172771), CABP4 (ENSG00000175544), CALML3 (ENSG00000178363), CALML5 (ENSG00000178372), CALN1 (ENSG00000183166), CALM1 (ENSG00000198668), EFCAB2 (ENSG00000203666), EFCAB7 (ENSG00000203965), EFCAB9 (ENSG00000214360)

Protein

Protein identifiers

Centrin-1Q12798 (reviewed: Q12798)

Alternative names: Caltractin isoform 2

All UniProt accessions (2): Q12798, A0A140VJG3

UniProt curated annotations — full annotation on UniProt →

Function. Plays a fundamental role in microtubule-organizing center structure and function. Plays a role in sperm cilia formation.

Subunit / interactions. Monomer. Interacts with CIMAP3. Interacts with USP49.

Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Cell projection. Cilium.

Miscellaneous. Binds two moles of calcium per mole of protein.

Similarity. Belongs to the centrin family.

RefSeq proteins (1): NP_004057* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000629RNA-helicase_DEAD-box_CSConserved_site
IPR002048EF_hand_domDomain
IPR011992EF-hand-dom_pairHomologous_superfamily
IPR018247EF_Hand_1_Ca_BSBinding_site
IPR050145Centrin_CML-likeFamily

Pfam: PF13499

UniProt features (16 total): binding site 10, domain 4, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q12798-F186.620.69

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (10): 52; 150; 152; 154; 156; 161; 41; 43; 45; 47

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-9613829Chaperone Mediated Autophagy
R-HSA-9615710Late endosomal microautophagy
R-HSA-9646399Aggrephagy

MSigDB gene sets: 101 (showing top): MULLIGHAN_NPM1_SIGNATURE_3_UP, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_CENTRIOLE_ASSEMBLY, OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN, WTGAAAT_UNKNOWN, GOCC_CENTROSOME, OCT1_06, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_RESPONSE_TO_HEAT, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOCC_NEURON_PROJECTION, GOBP_CENTROSOME_DUPLICATION, GOCC_SPINDLE, GOCC_CENTRIOLE, GOCC_MOTILE_CILIUM

GO Biological Process (4): microtubule cytoskeleton organization (GO:0000226), centriole replication (GO:0007099), cellular response to heat (GO:0034605), cell division (GO:0051301)

GO Molecular Function (6): calcium ion binding (GO:0005509), microtubule binding (GO:0008017), G-protein beta/gamma-subunit complex binding (GO:0031683), heterotrimeric G-protein binding (GO:0032795), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (11): spindle pole (GO:0000922), nucleus (GO:0005634), centrosome (GO:0005813), centriole (GO:0005814), cytosol (GO:0005829), photoreceptor connecting cilium (GO:0032391), cytoplasm (GO:0005737), microtubule organizing center (GO:0005815), cytoskeleton (GO:0005856), cilium (GO:0005929), cell projection (GO:0042995)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Autophagy2
Selective autophagy1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure5
protein-containing complex binding2
microtubule organizing center2
intracellular membraneless organelle2
cytoskeleton organization1
microtubule-based process1
cell cycle process1
centrosome duplication1
centriole assembly1
response to heat1
cellular response to stress1
cellular process1
metal ion binding1
tubulin binding1
binding1
cation binding1
spindle1
intracellular membrane-bounded organelle1
centriole1
cytoplasm1
ciliary transition zone1
photoreceptor cell cilium1
intracellular anatomical structure1
microtubule cytoskeleton1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1

Protein interactions and networks

STRING

2496 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CETN1PCNTO95613870
CETN1NINQ8N4C6844
CETN1PCM1Q15154740
CETN1NUP85Q9BW27714
CETN1POC5Q8NA72709
CETN1SFI1A8K8P3693
CETN1MORN1Q5T089677
CETN1CEP290O15078667
CETN1DCTN2Q13561646
CETN1CEP135Q66GS9644
CETN1CENPAP49450643
CETN1DCTN1Q14203635
CETN1CEP164Q9UPV0631
CETN1PLK4O00444620
CETN1SASS6Q6UVJ0618

IntAct

38 interactions, top by confidence:

ABTypeScore
CETN1POC5psi-mi:“MI:0915”(physical association)0.850
POC5CETN1psi-mi:“MI:0915”(physical association)0.850
CETN1SGSM1psi-mi:“MI:0915”(physical association)0.780
SGSM1CETN1psi-mi:“MI:0915”(physical association)0.780
XPCCETN3psi-mi:“MI:0914”(association)0.730
KBTBD7METTL15psi-mi:“MI:0914”(association)0.730
CETN1POC5psi-mi:“MI:0915”(physical association)0.670
SGSM1CETN1psi-mi:“MI:0915”(physical association)0.660
CETN1SFI1psi-mi:“MI:0914”(association)0.640
SNX9WASLpsi-mi:“MI:0914”(association)0.640
TRDNTMEM223psi-mi:“MI:0914”(association)0.640
ZFAND5CETN1psi-mi:“MI:0915”(physical association)0.590
SGSM1CETN2psi-mi:“MI:0914”(association)0.530
PNMA2CCDC85Cpsi-mi:“MI:0914”(association)0.530
CETN1CCP110psi-mi:“MI:0914”(association)0.350
USP49ANKRD28psi-mi:“MI:0914”(association)0.350
CALN1CETN1psi-mi:“MI:0914”(association)0.350
CNN3ATE1psi-mi:“MI:0914”(association)0.350
LGALS3BPACACBpsi-mi:“MI:0914”(association)0.350

BioGRID (106): SGSM1 (Two-hybrid), POC5 (Two-hybrid), XPC (Affinity Capture-MS), POC5 (Affinity Capture-MS), SGSM1 (Affinity Capture-MS), KIAA1407 (Affinity Capture-MS), SFI1 (Affinity Capture-MS), SGSM2 (Affinity Capture-MS), EFCAB11 (Affinity Capture-MS), KIF1A (Affinity Capture-MS), TDP1 (Affinity Capture-MS), FBXO16 (Affinity Capture-MS), KIF1B (Affinity Capture-MS), CETN2 (Affinity Capture-MS), TWIST1 (Affinity Capture-MS)

ESM2 similar proteins: A0A125YHX7, A0A125YZN2, J9W034, O15182, O23184, O35648, O74435, O82659, P02597, P02599, P04352, P05434, P05933, P06704, P27163, P27164, P27482, P41041, P41208, P41209, P41210, P43645, P43646, P49258, P53440, P53441, P54213, P60204, P60205, P60206, P61859, P61860, P61861, Q06827, Q12798, Q24956, Q27177, Q27178, Q27179, Q2TBN3

Diamond homologs: A0A125YHX7, A0A125YZN2, A2WN93, A2WNH1, A2Y609, A3E3H0, A3E4D8, A3E4F9, A4UHC0, A8CEP3, A8I1Q0, J9W034, O15182, O23184, O35648, O60041, O74435, O82018, O82659, O94739, O96102, P02597, P02598, P04352, P04353, P04464, P05419, P05434, P06704, P06787, P07463, P0DH95, P0DH96, P0DH97, P0DH98, P11120, P11121, P13868, P15094, P17928

SIGNOR signaling

2 interactions.

AEffectBMechanism
CCP110“up-regulates activity”CETN1binding
PCM1up-regulatesCETN1relocalization

Disease & clinical

Clinical variants and AI predictions

ClinVar

33 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance29
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
253646GRCh37/hg19 18p11.32-11.22(chr18:14316-10784606)x1Pathogenic

SpliceAI

71 predictions. Top by Δscore:

VariantEffectΔscore
18:580607:G:GTdonor_gain0.6900
18:580643:G:Tdonor_gain0.6900
18:580603:G:GTdonor_gain0.6400
18:580539:G:GTdonor_gain0.5800
18:580643:G:GTdonor_gain0.5800
18:580765:G:Tdonor_gain0.5700
18:580573:G:GAdonor_gain0.5500
18:580636:G:GAdonor_gain0.5500
18:580765:G:GTdonor_gain0.5400
18:580572:T:TAdonor_gain0.5300
18:580511:G:GTdonor_gain0.5100
18:580604:A:Tdonor_gain0.5100
18:580635:T:TAdonor_gain0.5000
18:580926:G:GTdonor_gain0.5000
18:580511:G:Tdonor_gain0.4900
18:580942:C:Gdonor_gain0.4900
18:580464:T:TAdonor_gain0.4700
18:580465:G:GAdonor_gain0.4700
18:580654:G:Tdonor_gain0.4500
18:580733:GCCT:Gdonor_gain0.4400
18:580644:A:Tdonor_gain0.4100
18:581119:A:Gacceptor_gain0.4100
18:580539:G:Tdonor_gain0.4000
18:580575:C:Gdonor_gain0.4000
18:580615:G:GTdonor_gain0.3900
18:580755:A:Gdonor_gain0.3900
18:580934:TTCAG:Tdonor_gain0.3900
18:581118:A:AGacceptor_gain0.3900
18:580648:C:Tdonor_gain0.3800
18:580718:G:GTdonor_gain0.3800

AlphaMissense

1165 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
18:580517:T:CF37L0.999
18:580519:T:AF37L0.999
18:580519:T:GF37L0.999
18:580785:T:CL126P0.999
18:580796:G:CA130P0.999
18:580736:T:CF110L0.998
18:580738:C:AF110L0.998
18:580738:C:GF110L0.998
18:580745:T:CF113L0.998
18:580747:T:AF113L0.998
18:580747:T:GF113L0.998
18:580833:T:CL142P0.998
18:580853:G:CA149P0.998
18:580892:T:CF162L0.998
18:580894:C:AF162L0.998
18:580894:C:GF162L0.998
18:580524:T:CL39P0.997
18:580575:C:AA56D0.997
18:580589:G:CG61R0.997
18:580673:T:CF89L0.997
18:580675:C:AF89L0.997
18:580675:C:GF89L0.997
18:580743:T:CL112P0.997
18:580770:T:CI121T0.997
18:580770:T:GI121S0.997
18:580842:T:CM145T0.997
18:580842:T:GM145R0.997
18:580893:T:CF162S0.997
18:580514:G:CA36P0.996
18:580566:T:CL53P0.996

dbSNP variants (sampled 300 via entrez): RS1001462669 (18:578841 G>A), RS1001827434 (18:579955 G>A), RS1002206172 (18:579635 A>G), RS1002847989 (18:582340 A>C), RS1004119797 (18:579885 T>A,G), RS1005390171 (18:582199 C>T), RS1005462096 (18:581810 CT>C), RS1005926859 (18:581310 T>G), RS1006207018 (18:580997 G>A,C), RS1007931052 (18:578791 G>T), RS1008740468 (18:579645 A>G), RS1009896178 (18:579888 T>A), RS1009976542 (18:580663 C>T), RS1011811204 (18:578598 GT>G,GTT), RS1011968640 (18:581661 G>A)

Disease associations

OMIM: gene MIM:603187 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases methylation1
butyraldehydeincreases expression1
CGP 52608affects binding, increases reaction1
Atrazineincreases expression1
Benzo(a)pyreneaffects methylation, decreases methylation1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.